The higher levels of Caspase-1 p20 and IL-18 indicated more severe symptoms and worse prognosis in patients with COVID-19 (Rodrigues et al., 2021), suggesting that NLRP3 inflammasome is not only activated but also plays a key role in COVID-19 progression. Here, CASP1 is linked to COVID-19.